Xbrane Biopharma’s Shares Offering

Baker McKenzie advised Xbrane Biopharma on the deal. Xbrane Biopharma AB (publ) executed a primary issuance of shares of approximately SEK 170 million at a subscription price...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

BioInvent’s Shares Offering

Baker McKenzie acted as legal advisor to Kempen & Co and Pareto Securities on the deal. BioInvent International has carried out a primary issuance of shares...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Abliva’s Shares Offering

Baker McKenzie acted as legal advisor to the banks, while Cirio advised Abliva on the deal. Abliva has carried out a primary issuance of shares of...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

4C Strategies’ Shares Offering

Baker McKenzie acted as legal advisor to 4C Strategies, Priveq and Andreas Hedskog e.g. in the deal. 4C Strategies’ shares started trading on Nasdaq First North...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here